We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable Device Could Test for Physical Property of Tumor Aggressiveness

By LabMedica International staff writers
Posted on 24 May 2015
A new polarimetric fiber stress sensor device has been developed for visco-elastic and biomimetic material analysis, and, as part of the emerging field of physical oncology, is being tested for measuring a tumor’s Young’s modulus—an elasticity-related measure recently linked to cancerous tumor aggressiveness.

Engineers from the Viterbi School of Engineering at the University of Southern California (LA, CA, USA) developed the device and in preliminary testing found that more aggressive tumors are generally stiffer, a complex relationship that requires further study. More...
The device itself is an important step in the challenge of developing non-destructive methods to characterize physical properties of biological materials, and will be suitable for a wide variety of applications. It is an all-fiber-based material analysis device based on optical polarimetry that is different from previous polarimetric systems which rely on free-space components.

"The device leaves the sample completely undamaged, which allows researchers to still perform other tests on it," said Mark Harrison, USC engineering graduate student. Previous detectors required time-consuming alignment and were highly sensitive to environmental vibration. To solve these problems, the new device uses fiber optics, taking a cue from telecommunications. The system adds force onto a sample on top of the optical fiber, changing the polarization of the laser inside in a predictable way that enables calculation of the Young's modulus.

"Instruments able to measure a material's Young's modulus already existed, but they're large and require calibration each time they're moved," said Andrea Armani, USC associate professor of engineering, "Our device could be carried from hospital room to hospital room and doesn't need an engineer to operate it."

Prof. Armani was inspired after a conversation with colleague David Agus, USC professor of medicine and engineering, who told her that Young’s modulus has been linked to tumor aggressiveness but he lacked an easy-to-use device for testing that metric. "This advancement from Prof. Armani is so exciting, as we now have a new dimension of a tumor to measure. We are studying the role of Young's modulus together with Prof. Armani to help personalize and improve a cancer patient's care," said Prof. Agus.

In addition to evaluating the device's role in a clinical setting, there is also increased interest on a more fundamental level: understanding how different types of tumors are related to their mechanical properties. Emphasis has mostly been placed on the chemical makeup of tumors so most current tests to probe the nature of cancerous tumors focus on chemical makeup—an important feature to understand, but only part of whole the picture. "Physical oncology represents a completely fresh approach to tackling the problem of cancer. It has the potential to provide huge insights as scientists throughout the world try to understand, treat, and ultimately prevent cancer in humans," said Peter Kuhn, USC professor who helped launch a new peer-reviewed journal on physical oncology.

"Given how safe, stable, and accurate this instrument is, it could play a pivotal role in both diagnostic and research efforts," said Prof. Armani. The team next will work with Prof. Agus to test it in a clinical setting. They also hope to create a more sensitive version of the device that can map Young’s modulus across tumors.

The study, by Harrison MC and Armani AM, was published online May 14, 2015, in the journal Applied Physics Letters.

Related Links:
University of Southern California 

New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: USU chemists Kadin Crosby, Bamidele Filani, and Ryan Jackson have reported newly discovered functions of CRISPR-Cas12a3 (Photo courtesy of USU/M. Muffoletto)

CRISPR Discovery Paves Way for Single Diagnostic Test for COVID, Flu and RSV

Immune systems across all forms of life defend against viruses by blocking their ability to replicate. Many CRISPR-based defenses achieve this by cutting viral DNA, but these approaches can damage host... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.